During the Covid-19 pandemic, Pfizer has used every opportunity to maximize its profits, even if this meant reduced access to life-saving medical products for most of the world. The same is about to happen in the case of Paxlovid, the company’s Covid-19 oral treatment

The Pope centered those caught in overlooked tragedies in his annual Christmas address, continuing his commitment to progressive change and work with movements for justice

While the world is discussing ways to move on from the pandemic and return to normalcy, an entire continent is struggling to get even the first dose of vaccine, with little concern expressed by international bodies

A new research shows that even a small quantity of the neutralising antibodies indicates a strong efficacy of the vaccine

What is standing in the way of expanding production and carrying out mass vaccination campaigns across the world?

A proposal made by India and South Africa in October last year to waive certain Intellectual Property Rights (IPR) of COVID vaccines has gained massive support across the world. Despite its potential to prevent millions of avoidable deaths, the US and its allies continue to block the proposal at the WTO.

While a public desperate for protection against COVID-19 is quick to shame “vaccine hunters,” the real culprits are the companies refusing to share their publicly funded intellectual property and the governments allowing them to get away with it.

Dr. Satyajit Rath talks about the progress of different vaccination campaigns and how the vaccines are faring against the different COVID variants.

Pfizer Inc. is accused of aiming for more profits by not ensuring the delivery of the promised quantity of COVID-19 vaccines after it was found that medics could draw six doses of vaccine per bottle instead of the expected five doses